Sell Your Healthcare Staffing Business

Healthcare Staffing

Sell Your Healthcare Staffing Business Into the Sector’s Most Active M&A Cycle

Healthcare staffing M&A continues at record levels. Cross Country Healthcare’s $437M Knox Lane PE deal, AMN’s strategic acquisitions, and dozens of PE-backed regional platforms all underscore the depth of buyer demand. Quality healthcare staffing operators with $2M+ EBITDA command 5x–9x multiples, with premium platforms hitting 12x+.

200+
Deals Sold
$800M+
Volume Sold
#1
Ranked by Axial
50
States Served
The Healthcare Staffing Market

Why Healthcare Staffing Is a Top PE M&A Category

Healthcare staffing combines structural demand growth (aging population, nurse shortage, physician burnout, MSP/program needs) with strong PE consolidation appetite. Cross Country’s PE take-private at $437M (~8x EBITDA implied) confirms the category is at the front of the wave.

$50B+
US healthcare staffing market
Travel nursing, locum tenens, allied health, perm placement, MSP and program management. Growing high-single-digit driven by aging demographics and structural shortages.
2.5x–12x
EBITDA multiples by tier
Small single-state firms: 2.5x–4x SDE. Profitable regional firms: 3.5x–5x SDE. Multi-state ($4M–$15M EBITDA): 5x–7x. Premium platforms ($15M+ EBITDA): 6x–9x+. Large nationals can hit 12x+.
$437M
Cross Country / Knox Lane (2025)
Cross Country Healthcare agreed to be taken private by Knox Lane PE at $437M (after Aya Healthcare’s $615M strategic offer fell apart due to FTC concerns).
Active
PE platform demand
AMN, Cross Country (now PE), CHG, Aya, Medical Solutions plus dozens of regional PE-backed platforms continue aggressive acquisition activity.
Healthcare Staffing Economics

Scale Dramatically Improves Multiples

Healthcare staffing multiples scale almost linearly with EBITDA size. Small single-state firms trade at low single-digit SDE. National platforms trade at double-digit EBITDA multiples. The gap is wider than in almost any other category — which is why building scale before exit matters so much.

Building to platform scale dramatically lifts multiples

Small single-state firms (under ~$1M revenue): 2.5x–4x SDE. Profitable regional firms: 3.5x–5x SDE. Small multi-state ($1M–$4M EBITDA): 4x–6x EBITDA. Mid-size ($4M–$15M EBITDA): 5x–7x. Premium scale platforms ($15M+ EBITDA): 6x–9x+ EBITDA. Large national agencies in traditional categories can command 8x–12x.

Healthcare staffing rate environments shift quickly. Travel nurse rates have normalized off COVID-era peaks. Multiples could compress further if rates continue declining. We’re not financial advisors — talk to your CPA and M&A counsel.

5x–9x
EBITDA multiples for quality healthcare staffing in 2025
Who’s Buying Healthcare Staffing Businesses

Healthcare Staffing Has a Concentrated Buyer Set

Healthcare staffing M&A is dominated by a small number of national platforms and PE roll-ups. Four buyer categories compete for quality deals:

National healthcare staffing platforms

AMN Healthcare, Cross Country (now Knox Lane PE), CHG Healthcare, Aya Healthcare, Medical Solutions, Vivian Health, Trustaff. These platforms pay premium multiples for businesses with strong nurse/clinician pools and MSP/program capabilities.

PE-backed regional and specialty platforms

Multiple PE-backed regional and specialty platforms acquire to build scale before potentially selling up to nationals. Often competitive on price for businesses in target specialties (locum tenens, allied health, perm placement).

Strategic acquirers (health systems, tech platforms)

Some health systems and healthcare tech platforms acquire staffing businesses for vertical integration or workforce platform plays. Less common but can pay premium multiples.

Search funds and SBA-leveraged operators

For healthcare staffing businesses under $1.5M EBITDA, individual operators with SBA financing are competitive buyers, especially for businesses with strong specialty or geographic focus.

What Drives Value

What Buyers Look For in Healthcare Staffing Acquisitions

Specialty mix, nurse/clinician pool quality, customer relationships, and EBITDA scale drive the biggest multiple swings.

Specialty mix (travel, locum, allied, perm)Locum tenens and allied health often command premium multiples vs. pure travel nursing. Perm placement also trades at higher multiples than temp travel. Diversified specialty mix supports premium multiples.
Nurse / clinician pool size & engagementActive candidate pool size, repeat-deployment rates, and engagement systems matter for buyer confidence. Strong reactivation rates and referral systems support premium multiples.
Customer relationships & MSP positionsDirect hospital/health system relationships and MSP (managed service provider) contract positions command premium multiples for revenue durability.
Customer & specialty concentrationNo single customer above 10–15% and balanced specialty mix support premium multiples.
Tech & workflow automationModern ATS, candidate engagement automation, and credentialing workflows support premium multiples by demonstrating scalability.
EBITDA scale & marginsAbove $2M EBITDA you become attractive to PE. Above $15M EBITDA you’re at the top of the multiple range. Margins typically run 5%–15% (gross margins higher).
The Process

How We Sell Your Healthcare Staffing Business

From your first valuation call to the wire hitting your account, we handle every stage of the exit. A typical transaction closes in 4–9 months. You focus on running the business; we run the deal.

01

Free Business Valuation

We benchmark your financials against current Healthcare Staffing comparables and active buyer demand to give you a real, defensible valuation — at no cost and no obligation.

02

Confidential Marketing

We approach the Healthcare Staffing buyers most likely to bid quickly first — typically PE platforms and strategic acquirers active in your category — then broaden the process.

03

Buyer Competition

We bring multiple qualified offers to the table — PE platforms, strategics, search funds, SBA buyers — and negotiate them against each other to drive price and terms.

04

Due Diligence & Close

We coordinate with your CPA, attorney, and the buyer’s diligence team to keep momentum and prevent the deal from drifting. Closings typically happen 60–120 days after LOI.

Recent Market Activity

Healthcare Staffing M&A Hit Record Levels in 2025

Across all buyer categories, healthcare staffing deal volume reached record levels through 2024 and 2025 — with PE share continuing to grow.

Cross Country / Knox Lane $437M deal
Cross Country agreed to be taken private by Knox Lane PE at $437M in 2025, after Aya Healthcare’s $615M strategic offer fell apart due to FTC concerns. Confirms category PE appetite.
AMN strategic acquisitions
AMN Healthcare continued strategic acquisitions through 2025 to expand specialty capabilities and tech platform.
Regional platform consolidation
Multiple PE-backed regional healthcare staffing platforms continued aggressive add-on activity through 2024–2025, especially in locum tenens and allied health.
Common Questions

Healthcare Staffing Sellers Ask Us

What is my healthcare staffing business actually worth?
Range is wide by size. Small single-state firms: 2.5x–4x SDE. Profitable regional firms: 3.5x–5x SDE. Small multi-state ($1M–$4M EBITDA): 4x–6x EBITDA. Mid-size ($4M–$15M EBITDA): 5x–7x. Premium platforms ($15M+ EBITDA): 6x–9x+. Specialty mix (locum, allied, perm) and MSP positions are the biggest variables. Get a free valuation.
Has the post-COVID rate normalization hurt multiples?
Yes — modestly. Travel nurse rate environments have normalized off COVID-era peaks, which has compressed revenue and EBITDA at many staffing businesses. Multiples adjusted somewhat but remain at strong levels — the PE consolidation thesis has held. Specialty staffing (locum, allied, perm) has been less affected than pure travel.
Is having MSP / program management positions really worth a premium?
Yes — meaningfully. MSP and program management contracts create much stickier customer relationships than per-diem or per-assignment placement. Buyers pay premiums for businesses with anchor MSP positions because they’re harder to displace. Often a 1–2 turn of EBITDA premium over businesses without MSP positions.
How long does it take to sell a healthcare staffing business?
Most transactions close within 4–9 months from start to wire. Smaller SBA-financed deals can move faster (3–5 months). Larger PE-led deals with quality-of-earnings reports and committee approvals can take 6–10 months. We give you a realistic timeline at the valuation call.
Will my employees, customers, or competitors find out I’m selling?
No. We never publish your business name. Every prospective buyer signs an NDA before seeing identifying details, and we vet financial qualifications before granting access to your data room.
Do I have to stay on after the sale?
Almost always for some transition period — 3 to 12 months is typical. Search-fund and PE buyers often want longer because they’re acquiring the relationships and knowledge as much as the assets. Shorter transitions are possible when the operation is genuinely turnkey.
What does Business Exits charge?
We work on a success-fee model — we get paid only when your deal closes. There are no upfront retainers and the valuation is free.
Our Team

Brokers Built From the Operator’s Side of the Table

Our brokers are former business owners themselves. That’s why the process is built around the things that actually matter to sellers — net proceeds, confidentiality, and not having the deal drift for a year.

Business Exits Team

Find Out What Your Healthcare Staffing Business Is Worth

Takes 15 minutes. No obligation. Just an honest number, benchmarked against current buyer demand and recent comparable transactions in your industry.

Get My Free Valuation →

Market Data Sources

Healthcare staffing market data from Scope Research, AHLA, and FOCUS (2025). EBITDA multiples from FOCUS Healthcare Dashboard, First Page Sage, and CTAcquisitions. Cross Country / Knox Lane and AMN transaction data from publicly disclosed deal announcements. Active acquirer examples are drawn from publicly disclosed transactions and firm marketing materials and do not imply an exclusive relationship with Business Exits. We are not tax or legal advisors; consult a CPA and attorney before any transaction.